HK1258694A1 - 減毒溶血曼海姆氏菌疫苗及其製造和用途 - Google Patents

減毒溶血曼海姆氏菌疫苗及其製造和用途

Info

Publication number
HK1258694A1
HK1258694A1 HK19101075.5A HK19101075A HK1258694A1 HK 1258694 A1 HK1258694 A1 HK 1258694A1 HK 19101075 A HK19101075 A HK 19101075A HK 1258694 A1 HK1258694 A1 HK 1258694A1
Authority
HK
Hong Kong
Prior art keywords
attenuated
making
methods
haemolytica vaccines
manheimia haemolytica
Prior art date
Application number
HK19101075.5A
Other languages
English (en)
Inventor
F Bey Russell
Kirubakaran Lawrence Paulraj
R Simonson Randy
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of HK1258694A1 publication Critical patent/HK1258694A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK19101075.5A 2012-11-08 2015-10-13 減毒溶血曼海姆氏菌疫苗及其製造和用途 HK1258694A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261723979P 2012-11-08 2012-11-08

Publications (1)

Publication Number Publication Date
HK1258694A1 true HK1258694A1 (zh) 2019-11-15

Family

ID=50685318

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15109964.6A HK1209317A1 (zh) 2012-11-08 2015-10-13 減毒溶血曼海姆氏菌疫苗及其製造和用途
HK19101075.5A HK1258694A1 (zh) 2012-11-08 2015-10-13 減毒溶血曼海姆氏菌疫苗及其製造和用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15109964.6A HK1209317A1 (zh) 2012-11-08 2015-10-13 減毒溶血曼海姆氏菌疫苗及其製造和用途

Country Status (9)

Country Link
US (8) US9370561B2 (zh)
EP (2) EP2916863B1 (zh)
AR (1) AR093424A1 (zh)
AU (2) AU2013342269B2 (zh)
BR (1) BR112015010364B1 (zh)
CA (1) CA2890466C (zh)
ES (1) ES2684556T3 (zh)
HK (2) HK1209317A1 (zh)
WO (1) WO2014074817A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015010364B1 (pt) 2012-11-08 2022-05-03 Boehringer Ingelheim Animal Health USA Inc. Vacinas atenuadas de mannheimia haemolytica e métodos de produção e uso
NL2018155B1 (en) * 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
US11690901B2 (en) * 2020-03-03 2023-07-04 The United States Of America, As Represented By The Secretary Of Agriculture Southern cattle tick vaccine product
CN115960184B (zh) * 2022-09-28 2023-12-12 华中农业大学 一种溶血性曼氏杆菌a6血清型白细胞毒素抗原蛋白、其抗体及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US5055400A (en) 1986-11-26 1991-10-08 University Of Guelph Leukotoxin gene of pasteurella haemolytica
CA2014033C (en) 1989-04-07 1993-02-09 Stephen D. Acres Compositions and treatments for pneumonia in animals
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
AUPN631395A0 (en) 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(II)
US5840556A (en) 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
WO1998016247A1 (en) 1996-10-11 1998-04-23 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
WO1998046260A1 (en) 1997-04-15 1998-10-22 Baylor College Of Medicine Pasteurella haemolytica vaccine
US5824556A (en) 1997-06-11 1998-10-20 Tarr; George E. Peptide mass ladders generated using carbon disulfide
NZ514103A (en) * 1997-09-25 2001-09-28 Biotechnology Res & Dev LktA deletion mutant of P. haemolytica
US6936262B2 (en) 1997-09-25 2005-08-30 Biotechnology Research And Development Corporation LktA deletion mutant of P. haemolytica
JP4144272B2 (ja) * 2002-07-10 2008-09-03 トヨタ自動車株式会社 内燃機関の燃料噴射量制御装置
US7351416B2 (en) 2003-07-02 2008-04-01 The United States Of America As Represented By The Department Of Agriculture Vaccines comprising acapsular P. multocida hyaE deletion mutants
US9102925B2 (en) 2009-02-02 2015-08-11 Washington State University Compositions and methods for treating or preventing conditions and diseases associated with Mannheimia haemolytica
BR112015010364B1 (pt) 2012-11-08 2022-05-03 Boehringer Ingelheim Animal Health USA Inc. Vacinas atenuadas de mannheimia haemolytica e métodos de produção e uso
US20170022510A1 (en) 2012-11-08 2017-01-26 Biotechnology Research And Development Corporation Attenuated Mannheimia haemolytica

Also Published As

Publication number Publication date
WO2014074817A3 (en) 2015-07-02
US20170246286A1 (en) 2017-08-31
US20160199477A1 (en) 2016-07-14
EP2916863A2 (en) 2015-09-16
CA2890466A1 (en) 2014-05-15
AR093424A1 (es) 2015-06-03
US10058601B2 (en) 2018-08-28
BR112015010364B1 (pt) 2022-05-03
CA2890466C (en) 2022-07-19
EP2916863B1 (en) 2018-05-30
BR112015010364A2 (pt) 2017-08-22
US20160243212A1 (en) 2016-08-25
AU2017202354B2 (en) 2019-02-21
US20170128560A1 (en) 2017-05-11
US20160158336A1 (en) 2016-06-09
US10039819B2 (en) 2018-08-07
US9675682B2 (en) 2017-06-13
US9744226B2 (en) 2017-08-29
AU2013342269B2 (en) 2017-02-02
EP3384927A1 (en) 2018-10-10
EP3384927B1 (en) 2022-07-06
US20170304424A1 (en) 2017-10-26
US20190000954A1 (en) 2019-01-03
AU2017202354A1 (en) 2017-05-11
ES2684556T3 (es) 2018-10-03
AU2013342269A1 (en) 2015-06-04
HK1209317A1 (zh) 2016-04-01
US20140170190A1 (en) 2014-06-19
WO2014074817A2 (en) 2014-05-15
US9370561B2 (en) 2016-06-21

Similar Documents

Publication Publication Date Title
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
IL239353A0 (en) Continuous production unit and methods for using it
HK1207001A1 (zh) 免疫刺激性組合物及其使用方法
HK1208439A1 (zh) -氮雜吲唑化合物及其使用方法
EP2895083A4 (en) LIGATOR AND METHOD FOR ITS USE
GB201510816D0 (en) Medical tubes and methods of manufacture
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
IL241878B (en) Macrolides and methods for their preparation and use
HK1203834A1 (zh) 減毒豬鏈球菌疫苗和其製造方法和用途
IL238227A0 (en) Antibodies against c16orf54 and uses thereof
EP2844903A4 (en) TUBES AND METHOD FOR THE PRODUCTION AND USE THEREOF
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
EP2806811A4 (en) VERTEBRAL CONSTRUCTION
EP2897639A4 (en) IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
HK1214138A1 (zh) 疫苗組合物及使用方法
EP2852397A4 (en) HUWENTOXIN IV VARIANTS AND METHODS OF USE
HK1209432A1 (zh) 抗鋸齒蛋白抗體及使用方法
HK1209325A1 (zh) 減毒的豬流感疫苗及其製備和使用方法
HK1258694A1 (zh) 減毒溶血曼海姆氏菌疫苗及其製造和用途
EP2678361A4 (en) COMPOSITIONS WITH IMPROVED IMMUNOGENICITY AND / OR REDUCED REACTIVITY AND METHOD OF USE THEREOF
EP2852413A4 (en) XENOANTIGEN WITH VACCINES AGAINST CANCER AND MANUFACTURING PROCESS THEREFOR
EP2906576A4 (en) GLYCOSPHINGOLIPIDES AND METHOD OF USE THEREOF
IL233961B (en) The composition of a phytogenic supplement and methods of its use